Literature DB >> 15784586

The UspA2 protein of Moraxella catarrhalis is directly involved in the expression of serum resistance.

Ahmed S Attia1, Eric R Lafontaine, Jo L Latimer, Christoph Aebi, George A Syrogiannopoulos, Eric J Hansen.   

Abstract

Many strains of Moraxella catarrhalis are resistant to the bactericidal activity of normal human serum. Previous studies have shown that mutations involving the insertion of an antibiotic resistance cartridge into the M. catarrhalis uspA2 gene resulted in the conversion of a serum-resistant strain to a serum-sensitive phenotype. In the present study, the deletion of the entire uspA2 gene from the serum-resistant M. catarrhalis strain O35E resulted in a serum-sensitive phenotype and did not affect either the rate of growth or the lipooligosaccharide expression profile of this mutant. Inactivation of the classical complement pathway in normal human serum with Mg2+ and EGTA resulted in the survival of this uspA2 mutant. In contrast, blocking of the alternative complement pathway did not protect this uspA2 mutant from complement-mediated killing. To determine whether the UspA2 protein is directly involved in serum resistance, transformation and allelic exchange were used to replace the uspA2 gene in the serum-resistant strain O35E with the uspA2 gene from the serum-sensitive M. catarrhalis strain MC317. The resultant O35E transformant exhibited a serum-sensitive phenotype. Similarly, when the uspA2 gene from the serum-resistant strain O35E was used to replace the uspA2 gene in the serum-sensitive strain MC317, the MC317 transformant acquired serum resistance. The use of hybrid O35E-MC317 uspA2 genes showed that the N-terminal half of the O35E protein contained a 102-amino-acid region that was involved in the expression of serum resistance. In addition, when the uspA2 genes from strains O35E and MC317 were cloned and expressed in Haemophilus influenzae DB117, only the O35E UspA2 protein caused a significant increase in the serum resistance of the H. influenzae recombinant strain. These results prove that the UspA2 protein is directly involved in the expression of serum resistance by certain M. catarrhalis strains.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15784586      PMCID: PMC1087425          DOI: 10.1128/IAI.73.4.2400-2410.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  57 in total

1.  The outer membrane proteins UspA1 and UspA2 of Moraxella catarrhalis are highly conserved in nasopharyngeal isolates from young children.

Authors:  Patricia Stutzmann Meier; Rolf Troller; Ioanna N Grivea; George A Syrogiannopoulos; Christoph Aebi
Journal:  Vaccine       Date:  2002-03-15       Impact factor: 3.641

2.  The major outer membrane protein of Haemophilus ducreyi consists of two OmpA homologs.

Authors:  J Klesney-Tait; T J Hiltke; I Maciver; S M Spinola; J D Radolf; E J Hansen
Journal:  J Bacteriol       Date:  1997-03       Impact factor: 3.490

3.  Complement resistance in Branhamella (Moraxella) catarrhalis.

Authors:  C Hol; C M Verduin; E van Dijke; J Verhoef; H van Dijk
Journal:  Lancet       Date:  1993-05-15       Impact factor: 79.321

4.  Mapping of a protective epitope of the CopB outer membrane protein of Moraxella catarrhalis.

Authors:  C Aebi; L D Cope; J L Latimer; S E Thomas; C A Slaughter; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

Review 5.  Moraxella catarrhalis: a review of an important human mucosal pathogen.

Authors:  R Karalus; A Campagnari
Journal:  Microbes Infect       Date:  2000-04       Impact factor: 2.700

6.  Functional characteristics of a protective monoclonal antibody against serotype A and C lipooligosaccharides from Moraxella catarrhalis.

Authors:  W G Hu; J Chen; J C McMichael; X X Gu
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

7.  Analysis of Moraxella catarrhalis by DNA typing: evidence for a distinct subpopulation associated with virulence traits.

Authors:  H J Bootsma; H G van der Heide; S van de Pas; L M Schouls; F R Mooi
Journal:  J Infect Dis       Date:  2000-04-13       Impact factor: 5.226

8.  Characterization of a multiple antibiotic resistance plasmid from Haemophilus ducreyi.

Authors:  P J Willson; W L Albritton; L Slaney; J K Setlow
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

9.  The Moraxella catarrhalis porin-like outer membrane protein CD is an adhesin for human lung cells.

Authors:  Melissa M Holm; Serena L Vanlerberg; Ian M Foley; Darren D Sledjeski; Eric R Lafontaine
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

10.  Repair of deoxyribonucleic acid in Haemophilus influenzae. I. X-ray sensitivity of ultraviolet-sensitive mutants and their behavior as hosts to ultraviolet-irradiated bacteriophage and transforming deoxyribonucleic acid.

Authors:  J K Setlow; D C Brown; M E Boling; A Mattingly; M P Gordon
Journal:  J Bacteriol       Date:  1968-02       Impact factor: 3.490

View more
  32 in total

1.  Genome analysis of Moraxella catarrhalis strain BBH18, [corrected] a human respiratory tract pathogen.

Authors:  Stefan P W de Vries; Sacha A F T van Hijum; Wolfgang Schueler; Kristian Riesbeck; John P Hays; Peter W M Hermans; Hester J Bootsma
Journal:  J Bacteriol       Date:  2010-05-07       Impact factor: 3.490

2.  A UspA2H-negative variant of Moraxella catarrhalis strain O46E has a deletion in a homopolymeric nucleotide repeat common to uspA2H genes.

Authors:  Wei Wang; Melanie M Pearson; Ahmed S Attia; Robert J Blick; Eric J Hansen
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

3.  Identification of two late acyltransferase genes responsible for lipid A biosynthesis in Moraxella catarrhalis.

Authors:  Song Gao; Daxin Peng; Wenhong Zhang; Artur Muszyński; Russell W Carlson; Xin-Xing Gu
Journal:  FEBS J       Date:  2008-09-13       Impact factor: 5.542

4.  Identification and characterization of a novel outer membrane protein (OMP J) of Moraxella catarrhalis that exists in two major forms.

Authors:  John P Hays; Saskia van Selm; Theo Hoogenboezem; Silvia Estevão; Kimberly Eadie; Peter van Veelen; Jan Tommassen; Alex van Belkum; Peter W M Hermans
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

5.  Antibodies against In Vivo-Expressed Antigens Are Sufficient To Protect against Lethal Aerosol Infection with Burkholderia mallei and Burkholderia pseudomallei.

Authors:  Shawn M Zimmerman; Jeremy S Dyke; Tomislav P Jelesijevic; Frank Michel; Eric R Lafontaine; Robert J Hogan
Journal:  Infect Immun       Date:  2017-07-19       Impact factor: 3.441

6.  Reptiles as a source of Salmonella O48--clinically important bacteria for children: the relationship between resistance to normal cord serum and outer membrane protein patterns.

Authors:  Gabriela Bugla-Płoskońska; Agnieszka Korzeniowska-Kowal; Katarzyna Guz-Regner
Journal:  Microb Ecol       Date:  2010-05-18       Impact factor: 4.552

7.  The Moraxella catarrhalis nitric oxide reductase is essential for nitric oxide detoxification.

Authors:  Wei Wang; Traci Kinkel; Willm Martens-Habbena; David A Stahl; Ferric C Fang; Eric J Hansen
Journal:  J Bacteriol       Date:  2011-03-25       Impact factor: 3.490

8.  Moraxella catarrhalis strain O35E expresses two filamentous hemagglutinin-like proteins that mediate adherence to human epithelial cells.

Authors:  Rachel Balder; Jonathan Hassel; Serena Lipski; Eric R Lafontaine
Journal:  Infect Immun       Date:  2007-03-19       Impact factor: 3.441

9.  Modular arrangement of allelic variants explains the divergence in Moraxella catarrhalis UspA protein function.

Authors:  Michael J Brooks; Jennifer L Sedillo; Nikki Wagner; Cassie A Laurence; Wei Wang; Ahmed S Attia; Eric J Hansen; Scott D Gray-Owen
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

10.  Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade.

Authors:  Ahmed S Attia; Sanjay Ram; Peter A Rice; Eric J Hansen
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.